NLH — Nova Leap Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$21.39m
- CA$22.95m
- $25.76m
- 81
- 89
- 79
- 97
Annual cashflow statement for Nova Leap Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.26 | 1.76 | -0.836 | -1.05 | 1.38 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.76 | -0.397 | 1.24 | 2.58 | -1.14 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.648 | -0.596 | -0.11 | 0.1 | 0.242 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 3.01 | 2.18 | 1.02 | 2.15 | 1.39 |
| Capital Expenditures | -0.007 | 0 | -0.071 | -0.028 | -0.025 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.56 | -7.4 | 0.015 | 0.005 | -1.57 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -1.56 | -7.4 | -0.056 | -0.023 | -1.59 |
| Financing Cash Flow Items | -0.375 | -0.229 | -0.285 | -0.056 | -0.007 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.325 | 4.33 | -1.41 | -2.52 | 0.73 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.14 | -1.05 | -0.461 | -0.378 | 0.508 |